SMARCE1 and neoplasm: Three weeks after injection, lung tumor burden was ∼10-fold lower in mice injected with SMARCE1-inhibited cancer cells on the DOX diet compared with mice injected with cells on the standard diet (SI Appendix, Fig. S4).